Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: lapatinib ditosylate|DRUG: Doxil
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)